전이성 흑색종 치료제 시장 : 요법별, Stage별, 최종사용자별, 지역별
Metastatic Melanoma Therapeutics Market, By Therapy, By Stages, By End User, By Geography
상품코드
:
1673044
리서치사
:
Coherent Market Insights
발행일
:
2025년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 전이성 흑색종 치료제 시장 규모는 2025년 80억 달러, 2032년에는 180억 2,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 12.3%의 성장률을 보일 것으로 예상됩니다.
| 보고 범위 |
보고서 상세 내용 |
| 기준 연도 |
2024년 |
2025년 시장 규모 |
80억 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
12.30% |
2032년 가치 예측 |
180억 2,000만 달러 |
그림. 전이성 흑색종 치료제 시장 점유율(%), 지역별 2025년
전이성 흑색종은 생명을 위협하는 피부암의 일종으로 흑색종 피부암이 신체의 다른 장기로 전이되어 발생합니다. 최근 연구에 따르면, 2020년 전 세계적으로 20만 명 이상의 신규 흑색종 환자가 보고되어 가장 흔한 암 중 하나가 될 것으로 예상됩니다. 전 세계적으로 흑색종 발병률 증가와 전이성 흑색종과 관련된 높은 사망률로 인해 이 적응증에 대한 새로운 치료 접근법에 대한 광범위한 조사가 진행되고 있습니다. 최근 몇 가지 표적치료제와 면역치료제가 전이성 흑색종 치료제로 승인되었습니다. 그러나 임상 결과를 개선하고 보다 효과적이고 안전한 치료 옵션에 대한 미충족 수요는 여전히 높습니다.
시장 역학
세계 전이성 흑색종 치료제 시장은 자외선 노출 증가로 인한 전 세계 흑색종 발병률 증가와 흑색종에 대한 인식이 높아짐에 따라 성장하고 있습니다. 또한, 새로운 표적 치료제와 면역관문억제제가 지속적으로 규제 당국의 승인을 받음에 따라 시장 범위가 더욱 확대되고 있습니다. 그러나 첨단 표적치료제 및 면역치료제와 관련된 고비용은 광범위한 채택에 영향을 미치는 큰 과제로 남아있습니다. 또한, 반응률과 내성 발생으로 인해 기존 치료법의 장기적인 사용에는 한계가 있습니다. 병용요법과 같은 혁신적인 치료 전략의 개발은 현재의 미충족 수요를 해결하고 향후 몇 년동안 시장 성장을 증가시킬 수 있는 큰 잠재력을 가지고 있습니다.
본 조사의 주요 특징
- 세계의 전이성 흑색종 치료제 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 CAGR을 조사하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계의 전이성 흑색종 치료제 시장의 주요 기업 프로파일을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터를 기준으로 정리하여 수록하였습니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계의 전이성 흑색종 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 전이성 흑색종 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 주요 발전
- 규제 시나리오
- 인수와 제휴 시나리오
- 자금조달과 투자
- PEST 분석
- Porter의 Five Forces 분석
제4장 세계의 전이성 흑색종 치료제 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부 이니셔티브
- 시장에 대한 COVID-19의 영향
제5장 세계의 전이성 흑색종 치료제 시장, 요법별, 2020년-2032년(10억 달러)
제6장 세계의 전이성 흑색종 치료제 시장, Stage별, 2020년-2032년(10억 달러)
- Stage 0
- Stage I
- Stage II
- Stage III
- Stage IV
제7장 세계의 전이성 흑색종 치료제 시장, 최종사용자별, 2020년-2032년(10억 달러)
제8장 세계의 전이성 흑색종 치료제 시장, 지역별, 2020년-2032년(10억 달러)
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- 기업 개요
- Johnson &Johnson Private Limited
- Sun Pharmaceutical Industries Limited
- Sanofi SA
- Bayer AG
- Lilly
- Merck &Co., Inc.
- GSK plc
- Novartis AG
- AbbVie Inc.
- Bausch Health Companies Inc.
- F. Hoffmann-La Roche Ltd
- Amgen Inc.
- AstraZeneca PLC
- Daiichi Sankyo Company, Limited
제10장 애널리스트 추천 사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제11장 조사 방법
LSH
영문 목차
Global Metastatic Melanoma Therapeutics Market is estimated to be valued at USD 8.00 Bn in 2025 and is expected to reach USD 18.02 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 8.00 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
12.30% |
2032 Value Projection: |
USD 18.02 Bn |
Figure. Metastatic Melanoma Therapeutics Market Share (%), By Region 2025
Metastatic melanoma is a life-threatening form of skin cancer that occurs due to the spread of melanoma skin cancer to other organs of the body. According to recent studies, over 200,000 new cases of melanoma were reported globally in 2020, making it one of the most common types of cancer. The rising global incidence of melanoma coupled with the high mortality rate associated with metastatic melanoma has driven extensive research into new therapeutic approaches for this indication. Several targeted therapies and immunotherapy drugs have been approved in recent years for the treatment of metastatic melanoma. However, there remains a significant unmet need for more effective and safer treatment options with improved clinical outcomes.
Market Dynamics:
The global metastatic melanoma therapeutics market is driven by the increasing incidence of melanoma worldwide due to rising UV radiation exposure and growing awareness about the disease. Moreover, continual approvals of novel targeted therapies and immune checkpoint inhibitors by regulatory agencies are further expanding the market scope. However, high costs associated with advanced targeted drugs and immunotherapy treatments remain a major challenge affecting broader adoption. Additionally, limitations in terms of response rate and emergence of resistance pose limitations on the long-term usage of existing therapies. The development of innovative treatment strategies, such as combination therapies, holds significant potential to address the current unmet needs and augment the market growth in the coming years.
Key Features of the Study:
- This report provides in-depth analysis of the global metastatic melanoma therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global metastatic melanoma therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Amgen, Bristol-Myers Squibb, Roche, Novartis, Merck, and Eli Lilly
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global metastatic melanoma therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global metastatic melanoma therapeutics market
Detailed Segmentation-
- By Therapy
- Chemotherapy
- Immunotherapy
- Targeted therapy
- Radiation therapy
- By Stages
- Stage 0
- Stage I
- Stage II
- Stage III
- Stage IV
- By End User
- Hospitals
- Cancer Centers
- Homecare
- Specialty Clinics
- Others
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Johnson & Johnson Private Limited
- Sun Pharmaceutical Industries Limited
- Sanofi S.A.
- Bayer AG
- Lilly
- Merck & Co., Inc.
- GSK plc
- Novartis AG
- AbbVie Inc.
- Bausch Health Companies Inc.
- Hoffmann-La Roche Ltd
- Amgen Inc.
- AstraZeneca PLC
- Daiichi Sankyo Company, Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapy
- Market Snapshot, By Stages
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Metastatic Melanoma Therapeutics Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Metastatic Melanoma Therapeutics Market, By Therapy, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Targeted therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Radiation therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Metastatic Melanoma Therapeutics Market, By Stages, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Stage 0
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Stage I
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Stage II
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Stage III
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Stage IV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Metastatic Melanoma Therapeutics Market, By End User, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cancer Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homecare
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Metastatic Melanoma Therapeutics Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Johnson & Johnson Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sun Pharmaceutical Industries Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lilly
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen Inc.
- AstraZeneca PLC
- Daiichi Sankyo Company, Limited
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. Research Methodology
- References
- Research Methodology
- About us and Sales Contact
관련자료
